Target intelligence / Profile preview

RNA, U6 small nuclear 275, pseudogene (RNU6-275P)

Target: RNU6-275P
Molecular classification: Other (Pseudogene), Non-coding RNA pseudogene

Overview

RNU6-275P is a pseudogene derived from the U6 small nuclear RNA family, which is a highly conserved non-coding RNA that forms a core part of the spliceosome responsible for pre-mRNA splicing in eukaryotic cells[1][2][4]. Pseudogenes like RNU6-275P are non-functional genomic elements that arise from ancestral gene duplication or retrotransposition events, and they do not produce functional RNA or protein products[2]. The canonical U6 snRNA is critical in RNA splicing, but the 275th pseudogene copy (RNU6-275P) is not biologically active and has no established physiological or therapeutic role.

Other names: RNU6-275PRNA, U6 small nuclear 275, pseudogene

Mechanism of action

None. No mechanism of action applies to pseudogenes.

Biological functions

Pseudogenes do not encode functional products; they generally do not have known direct biological functions.The active U6 snRNA (not the pseudogene) is essential for pre-mRNA splicing as a component of the spliceosome[1][2][4].

Disease associations

None known for this specific pseudogene.No established disease association for RNU6-275P.

Safety considerations

None.Pseudogenes do not code for functional proteins; they are not targets for therapy.

Interacting drugs

None.

1 more in the full profile.

Biomarkers

None specific to RNU6-275P.Some pseudogenes are studied as potential biomarkers, but there is no evidence that RNU6-275P serves this role.

Beyond the preview

Go deeper on RNA, U6 small nuclear 275, pseudogene (RNU6-275P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 275, pseudogene (RNU6-275P).

Explore the full profile